2024 APGCS Faculty

Alfred Kow

National University Hospital | Singapore

A renowned educator, A/Prof Kow has not only taught and mentored many batches of medical students, but has contributed widely to the field of surgery, particularly in general surgery, hepatobiliary surgery and liver transplantation. As a practicing surgeon at the Division of Hepatobiliary & Pancreatic Surgery, NUH, A/Prof Kow is a pioneer of many advanced surgical techniques in pancreatic surgery, liver surgery and biliary surgery. A/Prof Kow obtained his Master of Medicine (Surgery), Master of the Royal College of Surgeons of Edinburgh and Ireland diplomas in 2005 and subsequently, completed his advanced surgical training in Tan Tock Seng Hospital. In 2009, he obtained his Fellowship of the Royal College of Surgeons of Edinburgh (General Surgery) in Hong Kong. He was also accorded Specialist accreditation in General Surgery by Ministry of Health, Singapore in the same year.

Amit Rauthan

Manipal Hospitals | India

Dr. Amit Rauthan is a distinguished Medical Oncologist and the Head of the Department at Manipal Hospitals, Old Airport Road, Bangalore. With over 20 years of experience in cancer care, Dr. Rauthan is a leading expert in the integration of chemotherapy with biological therapies, immunotherapy, and targeted therapies in molecular oncology. He specializes in the treatment of hematological malignancies and solid tumors, including lung, breast, gastrointestinal, head, and neck cancers. Dr. Rauthan's expertise extends to precision oncology, where he has significantly contributed to the field of immuno-oncology in India. He is actively involved in clinical research as a principal investigator in numerous oncology trials and has authored and contributed to a wide range of research publications. A graduate of Smt. NHL Municipal Medical College with an MD in Internal Medicine and a DM in Oncology from Gujarat University, Dr. Rauthan is a respected member of prestigious organizations such as the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO), and the American Society of Hematology (ASH). In recognition of his contributions to the field, Dr. Rauthan has been honored with several awards, including the 'Times Healthcare Achievers' Award in Medical Oncology. His dedication to advancing cancer care and his commitment to patient well-being have made him a trusted and sought-after oncologist in India

Apoorva Gogna

Singapore General Hospital | Singapore

Dr Apoorva is Senior Consultant Interventional Radiologist in Singapore General Hospital Department of Vascular and Interventional Radiology, Clinical Associate Professor in Duke-NUS Medical School and Visiting Consultant in several public health institutes. His main interests are in diagnosis and minimally invasive treatments of cancers, vascular, lymphatic and urogenital disorders. He is principal investigator or co-investigator in several clinical trials and serves as Director for Intervention and Medical Devices Research in SingHealth Academic Clinical Programme.

Aung Lwin

Ng Teng Fong Hospital | Singapore

Dr Aung Lwin is a Senior Consultant, Division of Upper Gastrointestinal Surgery, Department of General Surgery, Ng Teng Fong General Hospital. His special interests include Upper Gastrointestinal Surgery and Bariatric & Metabolic Surgery. He is also an appointed Assistant Clinical Professor in Yong Loo Ling school of medicine, National University of Singapore.

Balamurugan Vellayappan

National University Cancer Institute | Singapore

Dr Bala graduated from National University of Singapore with a place on the Dean’s List and went on to complete his specialist training with the Royal Australian and New Zealand College of Radiologists, where he was awarded the CE Eddy medal. He then completed fellowship training at Liverpool Hospital, Sydney, Australia and stereotactic fellowship at the Ottawa Hospital Cyberknife Centre. He now serves as a Senior Consultant Radiation Oncologist at the National University Cancer Institute Singapore. His clinical and research interests are aligned in neuro-oncology, gastrointestinal oncology and high-precision treatments for the oligometastatic state. He is an active researcher with over 90 peer-reviewed publications and is the PI for several ongoing prospective studies.

Bhawna Sirohi

BALCO Medical Centre | India

Dr Bhawna Sirohi is the Medical Director at BALCO Medical Centre, Raipur and a Breast Medical Oncologist. She has more than two decades of experience as an oncologist in UK & India. Having qualified as an oncologist from Tata Memorial Centre, Mumbai, she further completed her training at Royal Marsden NHS Foundation Trust, UK. She has published more than 150 papers in national and international journals and has lectured worldwide. She has been involved in varied capacities to create cancer awareness in India be it through cancer screening camps in various states to the initial setting up of cancer centers in the private or public sector to enabling protocols and procedures for safe care of patients. She is deeply involved with charities like CanSupport and has even set up a charity New India Cancer Charity Initiative or NICCI.

Brian Goh

Singapore General Hospital | Singapore

Professor Goh is presently Head of the Department of Hepatopancreatobiliary and Transplant Surgery at Singapore General Hospital and the National Cancer Centre Singapore. He is also the Director of Singhealth Liver Transplant Service, and Chairman of Robotic Surgery, Division of Surgery, SGH. He is a highly-experienced and high-volume subspecialty HPB/transplant surgeon whose clinical practice focuses on the management of complex benign and malignant (cancers) conditions affecting the liver, pancreas, biliary tract and gallbladder.

Chan Wan Ying

National Cancer Centre Singapore | Singapore

Dr Chan Wan Ying received her medical degree from the National University of Singapore in 2012. She was awarded the fellowship of the Royal College of Radiologists and Master of Medicine in Diagnostic Radiology in 2016. She is currently an Associate Consultant in Oncologic Imaging at the NCCS. Her research interests include body imaging techniques, MR imaging and translational research. She has published in local and international journals and has been awarded Silver Prize for Best Scientific Exhibition Award.

Chee Cheng Ean

National University Cancer Institute Singapore | Singapore

Dr. Chee is a clinician-investigator and medical oncologist in gastrointestinal and hepatobiliary cancers in NCIS. As the Programme Director for the NUHS Medical Oncology Senior Residency [Fellowship] Programme, she is actively involved in the education of the Medical Oncology trainees and she also chairs the Colorectal Cancer Committee of the Singapore Cancer Society

Chen Ming-Huang

Taipei Veterans General Hospital | Taiwan (province of China)

Dr Ming-Huang Chen is the Director of the Division of Medical Oncology in the Department of Oncology at Taipei Veterans General Hospital, Taiwan. He is also the secretary general of Taiwan Oncology Society. With over 15 years of extensive clinical experience, he specializes in gastrointestinal tumors (esophageal cancer, gastric cancer, colorectal cancer, biliary tract cancer, and pancreatic cancer), and neuroendocrine tumors. He is also a clinical expert in the application of precision medicine and immunotherapy in cancer treatment. Beyond his clinical practice, Dr. Chen has a wealth of experience in investigator initiated trials (IIT) and publications. He actively contributes to teaching as a professor at National Yang-Ming Chiao- Tung University. He is widely recognized as an oncology precision expert and is frequently invited to share his expertise.

Chiun Hsu

National Taiwan University Hospital | Taiwan (province of China)

Chiun-Sheng Huang is the professor and chairman of Department of Surgery at the National Taiwan University Hospital and National Taiwan University College of Medicine. He is also the director of Breast Care Center at the National Taiwan University Hospital, Taipei, Taiwan. Dr Huang has dedicated his career to the prevention and treatment of breast cancer. His areas of research include: ultrasound in breast cancer screening and axillary staging; computer-aided diagnosis and detection of breast ultrasound; single nucleotide polymorphism and circulating tumor DNA as susceptibility and prognostic factor for breast cancer; and development of new regimens and biomarkers using neoadjuvant therapy.

Choo Su Pin

Curie Oncology | Singapore

Dr Choo Su Pin is a medical oncologist who specializes in gastrointestinal cancers including colorectal, upper gastrointestinal, pancreas, hepatobiliary, peritoneal, and anal cancers. She is also a visiting consultant at the National Cancer Centre, Singapore and Adjunct Associate Professor, Singhealth Duke-NUS Oncology Academic Clinic Programme, Duke-NUS Graduate Medical School Singapore. She was the Deputy Head of the Division of Medical Oncology prior to private practice and Chief of the Gastrointestinal Cancer Department from 2012 to 2018. Dr Choo graduated from the University of Nottingham Medical School, UK before returning to Singapore. She has fellowships from the Royal College of Physicians, UK and the Academy Of Medicine, Singapore and was trained in medical oncology at the National Cancer Centre Singapore (NCCS). She was one of the few overseas participants selected to participate in the AACR/ASCO Methods in Cancer Research Workshop, held in Vail in 2006. She also did a research fellowship at the University of California San Francisco where she worked on clinical trials for gastrointestinal cancers and undertook laboratory research on understanding neuroendocrine tumours. In 2011, Dr Choo obtained a SMU-Singhealth Graduate Diploma in Healthcare Management and Leadership. For her clinical care of patients, she received the Gold Excellent Service Award. She continues to use her experience in clinical research and currently serves as Deputy Chair of the Singhealth Centralised Institutional Review Board B which overseas research studies in oncology.

David Ng

Singapore General Hospital | Singapore

Dr David Ng completed his medical studies in 1990 and post-graduate medical training in Internal Medicine and Nuclear Medicine, becoming Member in the Royal College of Physicians (MRCP, UK) in 1996, Fellow of the Academy of Medicine in Nuclear Medicine (FAMS) in 1999 and Fellow of the Royal College of Physicians (FRCP, Edinburgh) in 2012. He completed an Fellowship in Nuclear Medicine and Clinical PET Imaging at the Clinical PET Centre, Guy’s, St Thomas’ and Kings’ Hospital, University of London and in the Hospital of the University of Pennsylvania, Philadelphia, USA. He is currently Senior Consultant and immediate past Head of the Department of Nuclear Medicine and Molecular Imaging (2014-2023), Singapore General Hospital, Clinical Professor at the Duke-NUS Medical School and Deputy Chair of Singhealth DUKE-NUS Radiological Sciences Academic Clinical Program (ACP) and Clinical Senior Lecturer with the National University of Singapore Yong Loo Lin School of Medicine. He was immediate past and Founding President of the Nuclear Medicine Society (Singapore) (2010-2020) and past Chair of the Chapter of Nuclear Medicine in the College of Radiologists, Singapore. He chairs and contributes to several committees under the Ministry of Health/National Environment Agency relating to health-care policies pertaining to Nuclear Medicine and Radiation Issues. His field of sub-expertise is in the treatment of thyroid cancers, radioimmunotherapy, radioembolization and other radionuclide theranostics, as well as PET/CT imaging, molecular diagnostic techniques and physiological mathematical modelling and collaborated with various other researchers and clinicians, with over 110 papers and 10 book chapters, including in the Journal of Nuclear Medicine, International Journal of Radiation Oncology Physics, Clinical Nuclear Medicine. He has given talks and lectures at regional and international conferences, particularly in nuclear theranostics and partition modelling of Y90 microspheres therapy.

David Tai

National Cancer Centre Singapore | Singapore

Dr David Tai is a Senior Consultant Medical Oncologist at National Cancer Centre Singapore. His area of interest is in gastrointestinal cancers and early developmental therapeutics. His research focus involves integrating basic science and translational models in devising new therapy for gastrointestinal malignancies. He is also involved in multiple ongoing trials focusing mainly on gastrointestinal cancers and phase 1 efforts. Dr Tai is a Clinical Associate Professor in Duke-NUS Medical School, Singapore and faculty for Duke-NUS Fundamental of Clinical Practice Course. He is also a clinical lecturer at Yong Yoo Lin School of Medicine, Singapore. He has participated actively in both undergraduate and postgraduate medical teachings.

Eileen Poon

National Cancer Centre Singapore | Singapore

Dr Eileen Poon is presently a Consultant Medical Oncologist at National Cancer Centre Singapore. Dr Poon obtained her medical degree from National University of Singapore in 2007. She subsequently completed her postgraduate internal medicine in National University of Singapore and did her postgraduate residency training in Medical Oncology. She also serves as the Vice President for Singapore Society of Oncology (SSO). She has a special interest in Adolescent and Young Adult Oncology (AYAO), which she has initiated the AYAO support group in NCCS in 2017. She also spearheaded a AYA team in NCCS to enhance the cancer care of AYA. Besides the clinical aspect, Dr Poon is keen to become an inspiring clinical educator too who is able to individualise teaching strategies to help each young doctor reach their full potential as she believes everyone learns differently with their own needs. Dr Poon has met wonderful inspiring mentors in her short career, and she recognize the importance of educating our younger doctors in order for not just science to be handed over, but also good doctoring. This is a skillset which she feels is increasingly underrated, especially with all the technology advancement.

Faye Lim

National Cancer Center Singapore | Singapore

Dr Faye Lim is a Senior Radiation Oncologist at the National Cancer Centre Singapore who specializes in both Breast and Gastrointestinal Cancers. She trained at the Mount Vernon Cancer Centre and the University College London Hospitals in the United Kingdom. She has a special interest in the use and optimization of proton therapy in breast and GI cancers and is the Clinical Lead for proton therapy in the treatment of breast cancer.

Han Shuting

National Cancer Center Singapore | Singapore

Dr. Han Shuting is a Consultant Medical Oncologist at the National Cancer Centre Singapore (NCCS). She graduated with Bachelor of Arts (Honours) from Christ’s College, Cambridge in 2010 and Bachelor of Medicine and Surgery (MBBChir) from Cambridge School of Clinical Medicine in 2013. Subsequently, she obtained her MRCP (UK) and MMed (Int. Med) accreditation in 2015. She completed her medical oncology training in NCCS in 2019. She is currently pursuing a PhD at the National University of Singapore under the National Medical Research Council (NMRC) research training fellowship award. She sub-specialises in gastrointestinal cancers and her areas of research include colorectal cancers, viral-driven cancers and immuno-oncology.

Ho Gwo Fuang

University Malaya Specialist Centre | Malaysia

Dr Ho Gwo Fuang is a Professor and clinical oncologist at University Malaya Medical Centre and University Malaya Specialist Centre, Kuala Lumpur, Malaysia. He was trained at Barts and The London National Health Service (NHS) Trust and The Royal Marsden NHS Trust in London. He attained his Certificate for Completion of Specialist Training (CCST) in 2007 and joined the Faculty of Medicine at University Malaya. He was the recipient of the Joint Commission International (JCI) Outstanding Young Malaysian Award in 2009 for medical innovation. His research interests involve breast, gastrointestinal and gynaecological cancers. He is involved in many national and international collaborative research work, as well as the training of new oncologists in Malaysia.

Hsieh Yao Yu

Taipei Medical University | Singapore

Dr. Hsieh Yao Yu is an Assistant Professor, Division of Hematology and Oncology at Taipei Medical University Shuang Ho Hospital. His reseacrh interest include Clinical trials, clinical data mining of Gastrointestinal tract cancer, drug resistance of chemotherapeutic drug in gastrointestinal tract cancer.

Iain Tan

National Cancer Centre Singapore | Singapore

Dr. Iain Tan is a Senior Consultant Medical Oncologist, leading the colorectal cancer service in the GI Oncology Team at the Department of Medical Oncology, National Cancer Centre Singapore. Dr Iain Tan, a clinician-scientist at A*STAR’s Genome Institute of Singapore (GIS), was awarded the prestigious Singapore Youth Award 2014. Dr Tan has been recognized for his contributions as a consultant oncologist at the National Cancer Singapore (NCCS) and research scientist at GIS, and for his efforts to cultivate an environment conducive for translational research. Dr Tan’s research focuses on new ways in the early detection and diagnosis of colorectal cancer.

Izuma Nakayama

National Cancer Center Hospital | Japan

Dr. Nakayama is a medical oncologist specializing in gastric cancer at National Cancer Center Hospital East. He received his degree in medicine from Okayama University Graduate School of Medicine and, received a Ph.D. from Tohoku University School of Medicine. He has a board-certificated medical oncologist recognized by Japanese Society of Medical oncology. Dr. Nakayama is an expert in clinical development of new anti-cancer therapies and initiates an ongoing clinical trial of neoadjuvant treatment for scirrhous-type gastric cancer. He is dedicated to clinical research particularly in young onset or CLDN18.2-positive gastric cancer. He published Review in Nature Reviews Clinical Oncology focusing on CLDN as a therapeutic target

Jennifer Leong

Sunway Medical Centre | Malaysia

Dr. Jennifer Leong Siew Mooi is a Consultant Clinical Oncologist at Sunway Medical Centre. Her key areas of interest lie in the management of hepatobiliary, lung and gynaecological cancers. She graduated with Masters in Clinical Oncology from University Malaya in 2015. Dr Jennifer is passionate about patients advocacy and raising public literacy on cancer awareness. She currently serves as an executive committee member in the City Cancer Challenge in Greater Petaling, a global initiative to improve access to equitable and quality cancer care in the local community. Dr. Jennifer is affiliated with multiple oncology societies, including MOS, ESMO, ESTRO, IASLC, and ASCO.

Jens Samol

Tan Tock Seng Hospital | Singapore

Dr Samol is the Clinical Lead for Thoracic Cancers, Lymphoma (within Medical Oncology) and Sarcoma as well as the Clinical Lead for Genetic Counselling and Clinical Cancer Genetics & Genomics Service at TTSH. He is the Director for Clinical Trials (CRIO), Co-Director (TTSH) for P.H.Feng Research Centre and is the Clinical Research Lead of the Medical Oncology Department at TTSH. Dr Samol holds a faculty appointment as an Assistant Professor at Lee Kong Chian School of Medicine, Singapore, as well as an Assistant Professor of Oncology at Johns Hopkins University School of Medicine, Baltimore, USA. He treats patients with all types of solid cancers and lymphoid neoplasms. He has a particular interest in Thoracic Cancers, Gastrointestinal Cancers (including HIPEC), Head & Neck Cancers, Sarcoma, and Lymphoma.

Johnny Ong

National Cancer Center Singapore | Singapore

Dr Johnny Ong is a Senior Consultant in the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore. He is also the Principal Investigator of the Laboratory of Applied Human Genetics, NCCS. Dr Ong is currently one of the only formally trained surgeons for sarcoma in Singapore. He is one of the key opinion leaders in the field of sarcoma and seeks to advance the care of sarcoma in Singapore and Asia Pacific.

Kai-Keen Shiu

University College London Hospitals | United Kingdom

Dr. Shiu is a Consultant in the Gastrointestinal Oncology Unit at University College London Hospital NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Institute. His research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary, as well as the development of novel cancer clinical trial designs. He is the Principal Investigator of the UCL/UCLH Gastrointestinal Cancer Translational Research Biobank and member of ASCO, ESMO and the Chair of the Association of Cancer Physicians New Consultant Group.

Kar Yong Wong

Tan Tock Seng Hospital | Singapore

Dr. Wong Kar Yong is a General Surgeon currently practising in Tan Tock Seng Hospital. His specialty interest is in colorectal cancer surgery, especially with the use of minimal invasive and robotic surgery. Dr. Wong specialises in minimal invasive colorectal cancer surgery. Majority of his colorectal surgeries were performed either via laparoscopically (key-hole) or robotically. He is proficient in advanced colorectal procedures such as extended lymph node dissection surgery in advanced colorectal cancer, transanal endoscopic microsurgery and colonic stenting. Besides cancer surgery, Dr. Wong is also experienced in management of benign coloproctology diseases and regularly performs surgery for haemorrhoids, anal fistula, anal fissure, perianal abscess etc. He is also an experienced endoscopist and has performed large numbers of therapeutic gastroscopy and colonoscopy on patients with good outcome

Kim Guowei

Crest Surgical Practice | Singapore

Dr. Kim Guowei is a Senior Consultant Upper Gastrointestinal, Bariatric and Robotic Surgeon. With a keen interest in undergraduate and postgraduate teaching and education, he served as a Clinical Lecturer for the Department of Surgery, Yong Loo Lin School of Medicine, NUS, from 2014 to 2021, before being appointed as an Assistant Professor in 2021. Asst Prof Kim has a strong interest in innovation in surgery, and strongly believes that keeping abreast with advances in technology is quintessential to give Singaporean patients access to the best medical care available.

Koo Si-Lin

National Cancer Centre Singapore | Singapore

Dr Koo Si-Lin is a Senior Consultant in Medical Oncology from the National Cancer Centre, Singapore. She graduated from the National University of Singapore with a Bachelor of Medicine, Bachelor of Surgery. She completed her Medical Oncology specialist training in 2014. She has a budding interest in cancer research and is developing her research in cancer immunology. She is actively engaged with researchers in Singhealth and A*STAR in developing translational research.

Matthew Ng

National Cancer Centre Singapore | Singapore

Dr Matthew Ng is the Head of GI Oncology at the National Cancer Centre Singapore and obtained his PhD from the Institute of Cancer Research (London, UK). He is the lead for Upper GI cancers, Director of the Investigational Medicine Unit for early phase trials. His research interest is in developing novel treatments for GI cancers.

Muhammad Azrif

Prince Court Medical Centre | Malaysia

Dr. Muhammad Azrif graduated from the Royal Free Hospital & University College London School of Medicine, London, UK in 1997. After completing his training in internal medicine and obtaining his MRCP (UK) in 2000, he entered the specialist training program in Clinical Oncology at the Christie Hospital, Manchester, UK. He became a Fellow of the Royal College of Radiologists (Clinical Oncology) in 2005 and attained his Certificate of Completion of Specialist Training (UK) before admission to the UK General Medical Council Specialist Register in 2006. He was awarded a one-year Clinical Research Fellowship to the Department of Radiation Oncology, University of Toronto, Canada in mid-2006. He returned to Malaysia in 2007 and served at the National University of Malaysia Medical Centre (UKMMC) as a Consultant Clinical Oncologist for 5 years before joining private practice in 2012. He has served on various national oncology committees, published in peer-reviewed journals as well as participated in numerous clinical trials, cancer advisory boards, and expert panels.

Pierce Chow

National Cancer Centre Singapore | Singapore

Prof. Pierce Chow is a senior consultant and Co-Director (Surgical) of the Comprehensive Liver Cancer Clinic at the National Cancer Centre Singapore, Senior Consultant Surgeon in HPB and Transplant Surgery at the Singapore General Hospital and Professor and Course Director at Duke-NUS Medical School Singapore. In addition to managing a busy HPB surgical oncology service, Prof. Chow has researched extensively on hepatocellular carcinoma (HCC). He leads collaborative research on the genomic heterogeneity of HCC and applications in precision medicine.

Raghav Sundar

National University Cancer Institute Singapore | Singapore

Dr Raghav Sundar is a Consultant Medical Oncologist specialising in Gastrointestinal cancers and early phase clinical trials. His clinical interest is in gastrointestinal cancers. His research interest lies in early phase drug development, immunotherapy, DNA damage repair, and chemotherapy-induced neuropathy. He has published in high impact peer-reviewed journals including Cancer Discovery and Clinical Cancer Research and designs clinical trials for novel cancer drugs.

Robert Walsh

National University Cancer Institute | Singapore

Dr Robert Walsh obtained his undergraduate medical degree from the University of Cambridge, England before undertaking Foundation training at the University Hospitals of Leicester NHS Trust. He has worked in the Singapore health system since 2013 and obtained his postgraduate qualifications from the Royal College of Physicians (UK) in 2015. Dr Walsh subsequently completed postgraduate residency training in Internal Medicine and Medical Oncology at the National University Health System, Singapore. His areas of clinical and research interests include gastrointestinal cancer, genitourinary cancer, and precision oncology.

Shaheenah Dawood

Mediclinic City Hospital | United Arab Emirates

Dr Shaheenah Dawood is a Consultant Medical Oncologist and Professor in Clinical Oncology in the United Arab Emirates. She was trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training, she was awarded multiple scholar training awards besides ASCO merit awards. Dr Shaheenah has served as an editorial fellow at the New England Journal of Medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles, and 12 book chapters. Having served as a reviewer for multiple journals including the Journal of Clinical Oncology she is currently leading the oncology clinical trials program at Mediclinic City Hospital, Dubai. She also serves as President of Excellence in Oncology Care (EIOC) annual congress held in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS), Asia Pacific Gastrointestinal Cancer Summit (APGCS) ,the international BRCA forum (iBRCAf) and Young Women Forum (YWF) from over a decade.

Shailesh Shrikhande

Tata Memorial Hospital | India

Professor Shailesh V. Shrikhande is Deputy Director of Tata Memorial Hospital, Mumbai. He is also Chief of Cancer Surgery and GI & HPB Surgical Service. He is one of the few surgeons worldwide to have successfully performed over 1200 Whipple operations. He has conducted over 60 live Operative teaching demonstrations of pancreatic, gastric, colorectal and gall bladder cancer surgeries across India. He is the Past President of the Indian Chapter of International Hepato-Pancreato-Biliary Association (IHPBA). He is also the President of the Asia Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) and also Secretary General Elect of the IHPBA. In recognition of his work on digestive cancer surgery in India, he was awarded Honorary Fellowship of the Royal College of Surgeons of England in 2014 (FRCS – Ad Eundem). In 2021, he was awarded Honorary Fellowship of American Surgical Association (ASA). He is the first Indian cancer surgeon and only the second Indian ever to receive this prestigious honour in the last 144 years of the world oldest surgical association.

Stephen L. Chan

The Chinese University of Hong Kong | Hong Kong

Dr. Stephen L. Chan is the Associate Clinical Professor of the Department of Clinical Oncology in the Chinese University of Hong Kong. He graduated from the University of Hong Kong in 2000 and obtained specialist qualification in Medical Oncology in 2007. He has been awarded the Gold Medal Prize for Dissertation in 2007 and Young Investigator award in 2008 by the Hong Kong College of Physician. His main research area is on clinical and traditional researches for gastrointestinal cancers, especially hepatobiliary and pancreatic cancers.

Thomas Yau

The University of Hong Kong | Hong Kong

Dr Yau graduated from the University of Hong Kong and started his medical oncology training initially at Queen Mary Hospital, Hong Kong. He was later employed as Specialist Registrar and Clinical Research Fellow at Royal Marsden Hospital, London. He also worked as a visiting faculty in Massachusetts General Hospital Cancer Centre, Harvard Medical School, Boston in 2010. He was conferred the Doctor of Medicine from the University of Hong Kong in 2012. His main research interests are gastrointestinal oncology, early phase clinical trials and translational research. He pioneered Hong Kong Liver Cancer classification and is one of the global pioneer in a drug development program in hepatocellular carcinoma. He had published more than 100 peer-review publications with articles in various leading oncology journals, namely Lancet, Lancet Oncology, Cell Stem Cell, Gastroenterology, Hepatology and Clinical Cancer Research. He had also delivered more than 150 invited regional and international lectures. He currently serves as associate editor and the editorial board members of many international peer-reviewed journals.

Toh Han Chong

National Cancer Centre Singapore | Singapore

Dr Toh is Senior Consultant and Deputy Chief Executive Officer (Strategic Partnerships), Division of Medical Oncology, National Cancer Centre Singapore. He graduated from the University of London, UK with an intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, UK. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, Massachusetts General Hospital, Harvard Medical School, Boston USA, and at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. He is also an alumni at the Harvard Business School General Management Program. Dr Toh is a recipient of the National Senior Clinician Scientist Award in 2017 and National Medical Excellence Award (NMEA) in 2018 for his pioneering work in cell and immunotherapy for cancer. He leads the NMRC LCG VICTORY (Virus-Induced Cancers Translational Oncology and immunologY) grant. As an Associate Professor and College Master at the Duke-NUS Graduate Medical School, Dr Toh is actively involved in medical education and training. He is the founding Chairman of the Singapore Society of Oncology Cancer Immunotherapy Consortium, co-founder of the Asia Pacific Gastroenterology Cancer Summit (APGCS), and faculty in the Cancer Immunology for the European Society of Medical Oncology (ESMO). Dr Toh has published over 132 peer review journal papers to date.

Yong Wei Peng

National University Cancer Institute | Singapore

Dr Yong Wei Peng obtained his medical degree and postgraduate training in University of Aberdeen, Scotland. After completing an oncology fellowship at the National University Hospital, he was awarded the A*star international clinical pharmacology fellowship at the University of Chicago. Upon his return to Singapore, he was awarded a three-year Investigatorship Award under the Clinician Scientist Award to further his research into personalized therapy. Dr Yong leads the therapeutic arm (NUH module) of the Singapore Gastric Cancer Consortium. The consortium received the prestigious five-year Translational Clinical Research grant in 2007. He is also the Chairman of the National Healthcare Group Domain-Specific Ethics Review Board. His clinical interest is in gastrointestinal cancers and his research interests are pharmacogenetics and epigenetics in cancer.

Yung-Yeh Su

National Institute of Cancer Research | Taiwan (province of China)

Dr. Su completed his medical education at Kaohsiung Medical University in 2012, obtained board certification in Oncology in 2019, and earned his Ph.D. at National Cheng Kung University in 2023. He currently holds the position of Assistant Investigator at the National Health Research Institutes and serves as a physician at National Cheng Kung University Hospital. Dr. Su's primary research focuses on clinical trials, as well as next-generation sequencing for gastrointestinal cancers. He has been honored with the Young Investigator Award from the Japanese Society of Medical Oncology (JSMO) in 2022, 2023, and 2024, and the Best Poster Award from the Taiwan Joint Cancer Conference (TJCC) in 2022 and 2023. Dr. Su has published over 20 articles in peer-reviewed journals, including the International Journal of Surgery, the British Journal of Cancer, and the Journal of Biomedical Science.